Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Transforming growth factor β (TGF-β) isoforms are secreted as inactive complexes formed through noncovalent interactions between the bioactive TGF-β entity and its N-terminal latency-associated peptide prodomain. Extracellular activation of the latent TGF-β complex is a crucial step in the regulation of TGF-β function for tissue homeostasis. We show that the fibrinogen-like (FBG) domain of the matrix glycoprotein tenascin-X (TNX) interacts physically with the small latent TGF-β complex in vitro and in vivo, thus regulating the bioavailability of mature TGF-β to cells by activating the latent cytokine into an active molecule. Activation by the FBG domain most likely occurs through a conformational change in the latent complex and involves a novel cell adhesion–dependent mechanism. We identify α11β1 integrin as a cell surface receptor for TNX and show that this integrin is crucial to elicit FBG-mediated activation of latent TGF-β and subsequent epithelial-to-mesenchymal transition in mammary epithelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190 · cited 1×
“1016/S0092-8674(00)80545-0 were determined by the comparative threshold cycle method with the Gapdh gene as a reference (Schmittgen and Livak, 2008).”
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“Indeed, several ECM molecules have been shown to induce the epithelial-to-mesenchymal transition (EMT), a cell process allowing conversion of polarized, adherent epithelial cells into motile, mesenchymal-like cells (Thiery et al., 2009).”
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527 · cited 1×
“Matrix molecules can also interact with cell–surface growth factor receptors or sequester growth factors in the ECM and activate them when needed (Hynes, 2009).”
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128 · cited 1×
“This complex then translocates into the nucleus and binds to the chromatin to regulate TGF-–responsive genes (Massagué, 2012).”
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Likewise, adenovirus-mediated overexpression of Smad7, a natural inhibitor of Smad signaling (Nakao et al., 1997), impaired both TGF-1– and FBG-induced phosphorylation of Smad2 (Fig.”
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793 · cited 3×
“…cotransfected with the pGL3-basic reporter plasmid (Promega) encoding firefly luciferase under the control of TGF-–responsive elements ((CAGA)9-Luc; Dennler et al., 1998) together with the phRLCMV vector (Promega) encoding Renilla luciferase under the control of the cytomegalovirus ubiquitous…”
InfluentialInman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634 · cited 2×
“SB431542, a small molecular weight inhibitor of the TGF- (TRI), Activin (ALK-4), and Nodal (ALK-7) type I receptors (Inman et al., 2002), was purchased from Sigma-Aldrich.”
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346 · cited 2×
“Although some RGD-dependent integrins have been shown to mediate a conformational change in the latent complex, causing bioactive TGF- to be exposed to cells (Munger et al., 1999; Asano et al., 2005, 2006; Wipff et al., 2007), we found that FBG-mediated TGF- activation does not require those integrins.”
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174 · cited 1×
“TSP-1 is the only matrix molecule described so far to bind and activate latent TGF- in vitro (Schultz-Cherry and Murphy-Ullrich, 1993; Schultz-Cherry et al., 1994) and in vivo (Crawford et al., 1998).”
Kim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166 · cited 2×
“The ECM thus acts as an epigenetic informational entity capable of integrating various extracellular cues so as to regulate multiple cell phenotypes and behaviors (Kim et al., 2011).”
Nelson, C. M., & Bissell, M. J. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104315 · Cited by 1,130 · cited 1×
“Dynamic cross talk between cells and the surrounding ECM is essential to tissue homeostasis (Nelson and Bissell, 2006).”
The regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832 · cited 1×
“Upon cleavage, the prodomain, called the latency-associated peptide (LAP), remains noncovalently bound to the mature (bioactive) TGFmoiety, maintaining it in a latent state by inhibiting its exposure to cell surface receptors (Moustakas and Heldin, 2009; Wu and Hill, 2009).”
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
Wu, M. Y., & Hill, C. S. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.012 · Cited by 746 · cited 1×
“Upon cleavage, the prodomain, called the latency-associated peptide (LAP), remains noncovalently bound to the mature (bioactive) TGF- moiety, maintaining it in a latent state by inhibiting its exposure to cell surface receptors (Moustakas and Heldin, 2009; Wu and Hill, 2009).”
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1
Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J. L., Munger, J. S., Kawakatsu, H., Sheppard, D., Broaddus, V. C., & Nishimura, S. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109100 · Cited by 729
Verrecchia, F., & Mauviel, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01641.x · Cited by 666 · cited 1×
“As TGF- is a potent actor in matrix protein synthesis and ECM remodeling (Verrecchia and Mauviel, 2002), it will be of interest to determine whether a local impairment of latent TGF- activation in TNX-deficient conditions would account for the observed decrease of ECM molecules.”
Disulfide bonds as switches for protein function
Hogg, P. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00057-4 · Cited by 620 · cited 2×
“Even though alkaline conditions are known to cause cysteine disulfhydryl bond reduction (Hogg, 2003), the FBG-mediated latent TGF- activation was specific, as alkaline-treated BSA did not show an enhancement of the Smad signaling compared with the untreated BSA (Fig.”
Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.-H., & Moustakas, A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0658 · Cited by 610 · cited 2×
“However, NMuMG cells seeded onto the FBG domain or in the presence of TGF-1, a potent inducer of EMT (Valcourt et al., 2005), adopted an elongated morphology, lost their close contacts, and scattered (Fig.”
Self-citationIntegrins and the activation of latent transforming growth factor β1 – An intimate relationship
Wipff, P.-J., & Hinz, B. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.01.012 · Cited by 517 · cited 1×
“Secreted TGF- isoforms are mainly sequestered in the ECM (Taipale et al., 1994, 1996; Nunes et al., 1997) and constitute a reservoir of signaling molecules that are activated when required.”
A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1.
Miyazono, K., Olofsson, A., Colosetti, P., & Heldin, C. H. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08049.x · Cited by 509 · cited 1×
“Latent TGF- can be found as a soluble entity, called the small latent complex (SLC; Miyazono et al., 1991), but it is also secreted as a large latent complex in which the SLC is covalently bound to a latent TGF-–binding protein (Miyazono et al., 1991).”
Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition
Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C.-H., & Moustakas, A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200512110 · Cited by 499 · cited 1×
“…() Fibronectin (Fn1) 5-CCCAGACTTATGGTGGCAATTC-3 (+) 200 58 40 NM_010233 5-AATTTCCGCCTCGAGTCTGA-3 () Hmga2 5-AGCAAAAACAAGAGCCCCTCTA-3 (+) 100 58 40 Thuault et al., 2006 5-ACGACTTGTTGTGGCCATTTC-3 () Snail1 (Snai1) 5-CCACTGCAACCGTGCTTTT-3 (+) 66 58 40 Thuault et al., 2008 5-CACATCCGAGTGGGTTTGG-3…”
Self-citationSchultz-Cherry, S. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.923 · Cited by 468 · cited 4×
“8 A; Schultz-Cherry and Murphy-Ullrich, 1993) and by competing LSKL peptide (Fig.”
InfluentialTaipale, J., Miyazono, K., Heldin, C., & Keski-Oja, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.171 · Cited by 448 · cited 11×
“Depending on the cell context, the latter mechanism might involve either various cell surface receptors, such as RGD-dependent integrins (Wipff and Hinz, 2008), or the ECM protein thrombospondin 1 (TSP-1; SchultzCherry and Murphy-Ullrich, 1993).”
InfluentialPiek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., & Dijke, P. T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4557 · Cited by 426
Nunes, I., Gleizes, P.-E., Metz, C. N., & Rifkin, D. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1151 · Cited by 395 · cited 12×
“Depending on the cell context, the latter mechanism might involve either various cell surface receptors, such as RGD-dependent integrins (Wipff and Hinz, 2008), or the ECM protein thrombospondin 1 (TSP-1; SchultzCherry and Murphy-Ullrich, 1993).”
InfluentialA recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Thuault, S., Tan, E.-J., Peinado, H., Cano, A., Heldin, C.-H., & Moustakas, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802016200 · Cited by 365 · cited 2×
“…() Snail1 (Snai1) 5-CCACTGCAACCGTGCTTTT-3 (+) 66 58 40 Thuault et al., 2008 5-CACATCCGAGTGGGTTTGG-3 () Zeb1 5-ACAAGACACCGCCGTCATTT-3 (+) 120 58 40 Thuault et al., 2008 5-GCAGGTGAGCAACTGGGAAA-3 () Gapdh 5-TGTGTCCGTCGTGGATCTGA-3 (+) 76 58 40 Valcourt et al., 2007 5-CCTGCTTCACCACCTTCTTGA-3…”
Ribeiro, S. M. F., Poczatek, M., Schultz-Cherry, S., Villain, M., & Murphy-Ullrich, J. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13586 · Cited by 353 · cited 2×
“8 C; Ribeiro et al., 1999).”
Physicochemical Activation of Recombinant Latent Transforming Growth Factor-beta's 1, 2, and 3
Brownh, P. D., Wakefiel, L. M., Levinson, A. D., & Sporn, M. B. (1990) · Growth Factors · doi:10.3109/08977199009037500 · Cited by 346 · cited 2×
“When these fractions were subjected to physicochemical conditions known to activate latent TGF-, i.e., heat denaturation and acid treatment (Brown et al., 1990), the signal was much higher (Fig.”
New regulatory mechanisms of TGF-β receptor function
Kang, J. S., Liu, C., & Derynck, R. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.05.008 · Cited by 328 · cited 1×
“T H E J O U R N A L O F C E L L B IO L O G Y JCB • VOLUME 205 • NUMBER 3 • 2014 410 411Activation of latent TGF- by tenascin-X • Alcaraz et al. phosphoinositide 3-kinase, and RhoA) to elicit regulation of other sets of genes (Kang et al., 2009).”
Koenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277 · cited 2×
“JCB: Article”
Shintani, Y., Fukumoto, Y., Chaika, N., Svoboda, R., Wheelock, M. J., & Johnson, K. R. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708137 · Cited by 267 · cited 1×
“For instance, type I collagen induces EMT by regulating diverse signaling cues (Koenig et al., 2006; Shintani et al., 2006, 2008a) and notably the TGF- pathway (Shintani et al., 2008b; DeMaio et al., 2012).”
Mao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261 · cited 1×
“Moreover, deficiency or haploinsufficiency of TNX both in patients and mice is correlated with a decreased content of collagen and elastic fibers in connective tissues, thus compromising their biomechanical properties (Mao et al., 2002; Zweers et al., 2004).”
Shintani, Y., Maeda, M., Chaika, N., Johnson, K. R., & Wheelock, M. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0071oc · Cited by 259 · cited 2×
“, 2006, 2008a) and notably the TGF- pathway (Shintani et al., 2008b; DeMaio et al., 2012).”
Transforming growth factor-beta complexes with thrombospondin.
Murphy-Ullrich, J. E., Schultz-Cherry, S., & Höök, M. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.181 · Cited by 257 · cited 2×
“FBG domain devoid of TGF-1 retains the ability to activate cell-secreted latent TGF-1 To obtain an FBG fraction devoid of TGF-, the recombinant FBG protein was further purified by affinity chromatography performed under alkaline conditions (pH 11), a procedure described to dissociate the TSP-1–TGF- complex (Murphy…”
The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry, S., Lawler, J., & Murphy-Ullrich, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47087-1 · Cited by 248 · cited 3×
“TSP-1 is the only matrix molecule described so far to bind and activate latent TGF- in vitro (Schultz-Cherry and Murphy-Ullrich, 1993; Schultz-Cherry et al., 1994) and in vivo (Crawford et al.”
Tiger, C.-F., Fougerousse, F., Grundström, G., Velling, T., & Gullberg, D. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0363 · Cited by 235 · cited 1×
“The 111 integrin was previously shown to specifically interact with several collagens, such as type I and IV collagens (Velling et al., 1999; Tiger et al., 2001), by binding to a GFOGER motif (Zhang et al., 2003).”
Taipale, J., Saharinen, J., Hedman, K., & Keski-Oja, J. (1996) · Journal of Histochemistry & Cytochemistry · doi:10.1177/44.8.8756760 · Cited by 224 · cited 11×
“Depending on the cell context, the latter mechanism might involve either various cell surface receptors, such as RGD-dependent integrins (Wipff and Hinz, 2008), or the ECM protein thrombospondin 1 (TSP-1; SchultzCherry and Murphy-Ullrich, 1993).”
Influentialα11β1 Integrin Recognizes the GFOGER Sequence in Interstitial Collagens
Zhang, W.-M., Käpylä, J., Puranen, J. S., Knight, C. G., Tiger, C.-F., Pentikäinen, O. T., Johnson, M. S., Farndale, R. W., Heino, J., & Gullberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210313200 · Cited by 179
Asano, Y., Ihn, H., Yamane, K., Jinnin, M., & Tamaki, K. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.041306 · Cited by 175 · cited 1×
“…some RGD-dependent integrins have been shown to mediate a conformational change in the latent complex, causing bioactive TGF- to be exposed to cells (Munger et al., 1999; Asano et al., 2005, 2006; Wipff et al., 2007), we found that FBG-mediated TGF- activation does not require those integrins.”
cDNA Cloning and Chromosomal Localization of Human α11 Integrin
Velling, T., Kusche-Gullberg, M., Sejersen, T., & Gullberg, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25735 · Cited by 160 · cited 1×
“The 111 integrin was previously shown to specifically interact with several collagens, such as type I and IV collagens (Velling et al., 1999; Tiger et al., 2001), by binding to a GFOGER motif (Zhang et al., 2003).”
Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., & Tamaki, K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21246 · Cited by 129 · cited 1×
“…some RGD-dependent integrins have been shown to mediate a conformational change in the latent complex, causing bioactive TGF- to be exposed to cells (Munger et al., 1999; Asano et al., 2005, 2006; Wipff et al., 2007), we found that FBG-mediated TGF- activation does not require those integrins.”
α 11β1 Integrin-Dependent Regulation of Periodontal Ligament Function in the Erupting Mouse Incisor
Popova, S. N., Barczyk, M., Tiger, C.-F., Beertsen, W., Zigrino, P., Aszodi, A., Miosge, N., Forsberg, E., & Gullberg, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00041-07 · Cited by 127 · cited 2×
“Authors observed a decreased expression of many matrix protein–encoding genes in mutant periodontal ligaments (Popova et al., 2007), but a putative defect of TGF- activation has not been addressed.”
Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage.
Tucker, R., Drabikowski, K., Hess, J., Ferralli, J., Chiquet‐Ehrismann, R., & Adams, J. C. (2006) · BMC Evolutionary Biology · doi:10.1186/1471-2148-6-60 · Cited by 121 · cited 2×
“…members (TNC, TNR, TNX, and TNW) share a similar domain pattern: an N-terminal assembly domain allowing tenascin oligomerization followed by a series of EGF-like domains, a variable number of FNIII (fibronectin type III) modules, and a C-terminal fibrinogen-like (FBG) domain (Tucker et al., 2006).”
Binding of tenascin‐X to decorin
Elefteriou, F., Exposito, J.-Y., Garrone, R., & Lethias, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02361-4 · Cited by 112 · cited 1×
“This protein has been shown to interact with ECM components, such as fibrillar (types I, III, and V) and fibril-associated (types XII and XIV) collagens, and the small proteoglycan decorin (Elefteriou et al., 2001; Lethias et al., 2006; Veit et al., 2006; Egging et al., 2007a).”
Self-citationCollagen XII Interacts with Avian Tenascin-X through Its NC3 Domain
Veit, G., Hansen, U., Keene, D. R., Bruckner, P., Chiquet-Ehrismann, R., Chiquet, M., & Koch, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603147200 · Cited by 104 · cited 1×
“This protein has been shown to interact with ECM components, such as fibrillar (types I, III, and V) and fibril-associated (types XII and XIV) collagens, and the small proteoglycan decorin (Elefteriou et al., 2001; Lethias et al., 2006; Veit et al., 2006; Egging et al., 2007a).”
Deficiency of Tenascin-X Causes Abnormalities in Dermal Elastic Fiber Morphology
Zweers, M. C., van Vlijmen-Willems, I. M., Kuppevelt, T. H. V., Mecham, R. P., Steijlen, P. M., Bristow, J., & Schalkwijk, J. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22401.x · Cited by 95 · cited 1×
“Moreover, deficiency or haploinsufficiency of TNX both in patients and mice is correlated with a decreased content of collagen and elastic fibers in connective tissues, thus compromising their biomechanical properties (Mao et al., 2002; Zweers et al., 2004).”
Shintani, Y., Wheelock, M. J., & Johnson, K. R. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1123 · Cited by 86 · cited 2×
“JCB: Article”
Tumour invasion and metastasis are promoted in mice deficient in tenascin‐X
Matsumoto, K., Takayama, N., Ohnishi, J., Ohnishi, E., Shirayoshi, Y., Nakatsuji, N., & Ariga, H. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00482.x · Cited by 81 · cited 1×
“In orthotopic experiments conducted on wild-type and TNX-deficient mice, TNX was found to restrain tumor cell invasion and metastasis formation in vivo (Matsumoto et al., 2001).”
A model of tenascin-X integration within the collagenous network
Lethias, C., Carisey, A., Comte, J., Cluzel, C., & Exposito, J.-Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.037 · Cited by 74 · cited 4×
“S1 A) as previously described (Lethias et al., 2001, 2006).”
InfluentialSelf-citationInteractions of human tenascin-X domains with dermal extracellular matrix molecules
Egging, D. F., van den Berkmortel, F., Taylor, G. D., Bristow, J., & Schalkwijk, J. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0706-9 · Cited by 70 · cited 4×
“As multiple TNX fragments are found in serum (Schalkwijk et al., 2001; Egging et al., 2007b), we immunoprecipitated TNX molecules comprising the C-terminal FBG domain from FBS with the anti-FBG antibody and used an ELISA to detect mature TGF-1 associated with the precipitates (Fig.”
InfluentialDeMaio, L., Buckley, S. T., Krishnaveni, M. S., Flodby, P., Dubourd, M., Banfalvi, A., Xing, Y., Ehrhardt, C., Minoo, P., Zhou, B., et al. (2012) · The Journal of Pathology · doi:10.1002/path.3016 · Cited by 60 · cited 2×
“, 2006, 2008a) and notably the TGF- pathway (Shintani et al., 2008b; DeMaio et al., 2012).”
Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis
Margaron, Y., Bostan, L. E., Exposito, J., Malbouyres, M., Trunfio-Sfarghiu, A.-M., Berthier, Y., & Lethias, C. (2010) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.12.011 · Cited by 57 · cited 2×
“The dried pellet was dissolved in 1 mM HCl, and collagen concentration was determined with the QuantiPro bicinchoninic acid assay kit (Margaron et al., 2010).”
Self-citationCell adhesion to tenascin‐X: Mapping of cell adhesion sites and identification of integrin receptors
Elefteriou, F., Exposito, J., Garrone, R., & Lethias, C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00563.x · Cited by 54 · cited 7×
“The FBG domain (from Gly3,911 to Gly4,135 residues) containing a C-terminal hexahistidine tag was also produced in Escherichia coli strain BL21(DE3) using the pT7-7 vector (United States Biochemical Corp.) as described previously (Elefteriou et al., 1999).”
InfluentialSelf-citationProteomic Identification of Matrix Metalloproteinase Substrates in the Human Vasculature
Stegemann, C., Didangelos, A., Barallobre-Barreiro, J., Langley, S. R., Mandal, K., Jahangiri, M., & Mayr, M. (2013) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.112.964452 · Cited by 50 · cited 3×
“, 2007b) and among the MMP substrates identified in human arteries in vitro (Stegemann et al., 2013).”
Functional role of Meox2 during the epithelial cytostatic response to TGF‐β
Valcourt, U., Thuault, S., Pardali, K., Heldin, C., & Moustakas, A. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.02.002 · Cited by 48 · cited 1×
“…(+) 66 58 40 Thuault et al., 2008 5-CACATCCGAGTGGGTTTGG-3 () Zeb1 5-ACAAGACACCGCCGTCATTT-3 (+) 120 58 40 Thuault et al., 2008 5-GCAGGTGAGCAACTGGGAAA-3 () Gapdh 5-TGTGTCCGTCGTGGATCTGA-3 (+) 76 58 40 Valcourt et al., 2007 5-CCTGCTTCACCACCTTCTTGA-3 () Accession numbers were obtained from GenBank.”
Self-citationA new adhesion assay using buoyancy to remove non-adherent cells
Goodwin, A. E., & Pauli, B. U. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00187-6 · Cited by 43 · cited 1×
“Nonadherent cells were removed, and adherent cells were fixed (10% [vol/vol] glutaraldehyde) using of the buoyancy method (Goodwin and Pauli, 1995).”
Lethias, C., Elefteriou, F., Parsiegla, G., Exposito, J., & Garrone, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010210200 · Cited by 38 · cited 5×
“…only, from Gly745 to Thr3,910 residues) and the FBG domain (C-terminal FBG domain, from Gly3,911 to Gly4,135 residues), were produced in stably transfected HEK-293 cells using the pSecTag2/hygromycin expression vector (Invitrogen) and purified as described previously (Lethias et al., 2001, 2006).”
InfluentialSelf-citationPommier, R. M., Gout, J., Vincent, D. F., Cano, C. E., Kaniewski, B., Martel, S., Rodríguez, J., Fourel, G., Valcourt, U., Marie, J. C., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120368 · Cited by 36 · cited 2×
“Luciferase activity in MCF10A-TRE-Luc and BL41-(CAGA)9-Luc cells was measured with the Luciferase Assay System (Promega), whereas the transcriptional responses in HT-1080 cells were determined with the Dual-Luciferase Reporter Assay System (Promega) using a luminometer (TD-20/20; Turner BioSystems) as described previo…”
MethodSelf-citationAmbort, D., Brellier, F., Becker‐Pauly, C., Stöcker, W., Andrejevic‐Blant, S., Chiquet, M., & Sterchi, E. E. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.08.007 · Cited by 35 · cited 5×
“TNC, the most studied member of the tenascin family, is cleaved in vitro by meprin-, releasing a 40–55-kD fragment containing the FBG domain along with two to three FNIII repeats (Ambort et al., 2010).”
InfluentialTenascin-X Induces Cell Detachment through p38 Mitogen-Activated Protein Kinase Activation
Fujie, S., Maita, H., Ariga, H., & Matsumoto, K. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1795 · Cited by 21 · cited 1×
“TNX has also been shown to regulate cell adhesion/deadhesion (Fujie et al., 2009) and thus to inhibit cell spreading in vitro (Elefteriou et al., 1999).”
Morissette, R., Merke, D. P., & McDonnell, N. B. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2013.12.004 · Cited by 21
Identification and characterization of multiple species of tenascin‐X in human serum
Egging, D. F., Peeters, A. C. T. M., Grebenchtchikov, N. I., Geurts-Moespot, A. J., Sweep, F. C. G. J., den Heijer, M., & Schalkwijk, J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05671.x · Cited by 18 · cited 6×
“As multiple TNX fragments are found in serum (Schalkwijk et al., 2001; Egging et al., 2007b), we immunoprecipitated TNX molecules comprising the C-terminal FBG domain from FBS with the anti-FBG antibody and used an ELISA to detect mature TGF-1 associated with the precipitates (Fig.”
InfluentialRogier, E., Dürrbach, A., Abécassis, L., Ferlicot, S., Snanoudj, R., Baudreuil, S., Arzouk, N., Vázquez, A., Charpentier, B., & Bourgeade, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00607.x · Cited by 18 · cited 4×
“Bourgeade (Institut National de la Santé et de la Recherche Médicale Unité 785, Villejuif, France) and was used as previously described (Rogier et al., 2005).”
InfluentialCharacterization of Mouse Serum Tenascin-X
Matsumoto, K., Kinoshita, T., Hirose, T., & Ariga, H. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.448 · Cited by 16 · cited 1×
“Serum TNX forms of different molecular weights have been found in human and mouse (Schalkwijk et al., 2001; Matsumoto et al., 2006; Egging et al., 2007b).”
Cited by
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
“By the way, FBG domain on tenascin-X, a member of tenascins, supports its mechanic interaction with TGF-β, then induce maturation of TGF-β, highlights the potential role of FBG domain on other tenascins in TGF-β maturation [250, 593].”
BackgroundTGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 458
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
“These interactions may deform LAP and also rely on cell adhesion via integrin a11b1 to promote activation (Alcaraz et al. 2014).”
Background
Metadata
- Authors
- Alcaraz, L. B., Exposito, J.-Y., Chuvin, N., Pommier, R. M., Cluzel, C., Martel, S., Sentis, S., Bartholin, L., Lethias, C., & Valcourt, U.
- Affiliations
- Lyon 1 Université (FR)
- Corresponding author
- Valcourt, Ulrich
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2014-05-12
- Volume
- 205
- Issue
- 3
- Pages
- 409-428
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC4018787
- OpenAlex
- W2041801047
- Cited by
- 94
- References
- 66
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 3 · 2021: 11 · 2020: 10 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 8
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- tenascin-X, epithelial-mesenchymal transition, latent TGF-beta activation, fibrinogen-like domain, cell adhesion, mammary epithelial cells, extracellular matrix, conformational change
- MeSH terms
- Animals, Cattle, Cell Adhesion, Epithelial Cells, Female, Humans, Mammary Glands, Animal, Phosphorylation, Protein Binding, Protein Conformation, Protein Precursors, Recombinant Proteins, Transfection, Signal Transduction, Integrins, Tenascin, RNA Interference, Receptors, Collagen, Mammary Glands, Human, Cell Line, Tumor, Mice, Smad Proteins, Transforming Growth Factor beta1, Protein Interaction Domains and Motifs, HEK293 Cells, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.